|
NeurogesX, Inc. Speciality BioPharmaceutical Focused on Chronic Peripheral Neuropathic Pain Management Therapies ( Qutenza )
Qutenza Patch (8% capsaicin) Lead Product Dermal Delivery System with Prescription Strength
Capsaicin Medicine, Approved by U.S. Food and Drug Administration and European EMEA in 2009
|
